NCT03162575

Brief Summary

The current study aims to investigate the efficacy of Mindfulness-Based Cognitive Therapy (MBCT) for reducing fatigue in Inflammatory Bowel Disease patients in remission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2017

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 22, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

July 18, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2019

Completed
Last Updated

August 5, 2024

Status Verified

August 1, 2024

Enrollment Period

11 months

First QC Date

May 1, 2017

Last Update Submit

August 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in fatigue

    Fatigue will be assessed with the Checklist Individual Strength (CIS-20)

    Change from baseline in severity of fatigue symptoms at 3 months, 6 months and 12 months

Secondary Outcomes (7)

  • Change in fatigue interference

    Change from baseline in fatigue interference at 3 months, 6 months, and 12 months

  • Change in anxiety

    Change from baseline in generalized anxiety at 3 months, 6 months, and 12 months

  • Change in depression

    Change from baseline in depression at 3 months, 6 months, and 12 months

  • Change in IBD-specific quality of life

    Change from baseline in quality of life at 3 months, 6 months, and 12 months

  • Change in sleep quality

    Change from baseline in sleep quality at 3 months, 6 months, and 12 months

  • +2 more secondary outcomes

Study Arms (2)

Mindfulness-Based Cognitive Therapy

EXPERIMENTAL

The intervention consists of 8 weekly sessions of MBCT. Each session will be administered in a group and will last 2.5 hours

Behavioral: Mindfulness-Based Cognitive Therapy

Waiting List Control

NO INTERVENTION

Patients assigned to the waiting list condition will receive no intervention for three months and afterwards will receive MBCT

Interventions

Structured MBCT intervention based on the protocol of Williams, Teasdale, and Segal (2002)

Also known as: MBCT
Mindfulness-Based Cognitive Therapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with either Crohn's disease or Ulcerative Colitis
  • Currently in remission
  • No expectation of a surgery in the upcoming three months
  • Score on the subscale 'subjective fatigue' of the CIS (8 items) ≥ 35 (i.e. indicating severe fatigue)
  • Age ≥ 18 and ≤ 75 years at the time of study entrance
  • Being able to attend eight weekly group sessions of 2.5 hours in the hospital
  • Being able to read, write, and speak Dutch.
  • Written informed consent

You may not qualify if:

  • Severe cognitive, neurological or psychiatric co-morbidity that could interfere with patients' participation and/or warrant other treatment, including acute suicidal ideations or behavior, diagnosis of schizophrenia or history of psychotic complaints, bipolar disorder, severe personality disorder, or history of clinically significant drug abuse or substance dependence
  • Pregnancy
  • Anemia (i.e. Hb \< 7.4 for women, \< 8.1 for men)
  • Change in IBD medication (i.e. use of steroids) within 1 month before study entry
  • Currently receiving psychological treatment for fatigue or for psychological/psychiatric problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMCG

Groningen, Netherlands

Location

Related Publications (2)

  • Tiles-Sar N, Neuser J, de Sordi D, Baltes A, Preiss JC, Moser G, Timmer A. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev. 2025 Apr 17;4(4):CD006913. doi: 10.1002/14651858.CD006913.pub3.

  • Bredero QM, Fleer J, Smink A, Kuiken G, Potjewijd J, Laroy M, Visschedijk MC, Russel M, van der Lugt M, Meijssen MAC, van der Wouden EJ, Dijkstra G, Schroevers MJ. Long-term treatment outcomes of mindfulness-based cognitive therapy for fatigue in patients with inflammatory bowel disease: Results of a randomized controlled trial. J Psychosom Res. 2024 Dec;187:111949. doi: 10.1016/j.jpsychores.2024.111949. Epub 2024 Oct 11.

MeSH Terms

Interventions

Mindfulness-Based Cognitive Therapy

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Maya Schroevers, PhD

    Department of Health Sciences

    PRINCIPAL INVESTIGATOR
  • Gerard Dijkstra, Prof.

    Center for Liver, Digestive and Metabolic Diseases (CLDM)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 1, 2017

First Posted

May 22, 2017

Study Start

July 18, 2017

Primary Completion

May 30, 2018

Study Completion

November 9, 2019

Last Updated

August 5, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations